Point72 (DIFC)’s Pfizer PFE Stock Holding History

Point72 (DIFC)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-888,542	Closed	-$25.9M	–	1724
2024 Q2	$24.9M	Buy	888,542 +882,135	+13,768%	+$24.3M	0.89%	9
2024 Q1	$178K	Buy	+6,407	New	+$178K	0.01%	985

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 (DIFC)'s PFE Position: Q3 2024 in Review

Point72 (DIFC) sold out of Pfizer (PFE) in Q3 2024, closing a stake of 888,542 shares — an estimated $25.9M sold.

Point72 (DIFC) first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $24.9M in Q2 2024. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Point72 (DIFC) reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Point72 (DIFC) sold 888,542 Pfizer shares in Q3 2024, an estimated $25.9M.
Point72 (DIFC) first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
Point72 (DIFC)'s Pfizer position peaked at $24.9M in Q2 2024.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Point72 (DIFC)'s 13F filing for Q3 2024, filed 14 Nov 2024.